Clinical significance of topoisomerase-II expression in patients with advanced non-small cell lung cancer treated with amrubicin.

Thorac Cancer · 2020 · PMC6997014 · PMID 31901017

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

A marginally significant difference in the PFS was detected between patients with different EGFR mutation statuses; thus, the EGFR mutation status may be a prognostic factor.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.